The efficacy and safety of irbesartan in primary hypertension even if a dose is missed: Results from the NO PROBLEM Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The efficacy and safety of irbesartan in primary hypertension even if a dose is missed: Results from the NO PROBLEM Study

Published:2009-12-03 Issue:sup1 Volume:19 Page:5-9
ISSN:0803-7051
Container-title:Blood Pressure
language:en
Short-container-title:Blood Pressure

Author:

Kabakci Giray,Kaya Baris Ergun,Tulumen Erol,Kocabas Ugur,Abali Gulcan,Deveci Onur,Aytemir Kudret,Tokgozoglu Lale,Ozkutlu Hilmi

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/08037050903444099

Reference14 articles.

1. Dose-Related Antihypertensive Effects of Irbesartan in Patients With Mild-to-Moderate Hypertension

2. Dose-Related Efficacy of Irbesartan for Hypertension

3. Safety of irbesartan in the treatment of mild to moderate systemic hypertension

4. 24-Hour blood pressure control by once-daily administration of irbesartan assessed by ambulatory blood pressure monitoring

5. Efficacy and Tolerability of Irbesartan, an Angiotensin II Receptor Antagonist, in Primary Hypertension

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exercise testing in hypertensive patients for assessing the cardiovascular protective potential of antihypertensive drugs;Therapeutic Advances in Cardiovascular Disease;2013-03-08

2. Chemistry and Biochemistry of Terpenoids fromCurcumaand Related Species;Journal of Biologically Active Products from Nature;2013-02

3. Twenty-four-hour ambulatory blood pressure measurement in clinical practice and research: a critical review of a technique in need of implementation;Journal of Internal Medicine;2011-03-14

4. Current awareness: Pharmacoepidemiology and drug safety;Pharmacoepidemiology and Drug Safety;2010-11-24

5. Implementation of 24-hour Blood Pressure Control;Blood Pressure;2010-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3